Table 1 Characteristics of included studies
Study | No. of patients | Age* | Male(%)* | Killip I (%)* | Diabetes (%)* | Glucose (%) | Insulin (U/500 ml) | Potassium (%) | Infusion rate (ml/kg/h) | Time from onset of symptom to treatment (h)* | 24-h glucose (mmol/L)* |
|---|---|---|---|---|---|---|---|---|---|---|---|
ECLA (1998)) | 470 | 58.2/60.5 | 77/68.3 | 84.4/86.3 | 18.5/18 | 25 | 50 | 0.3 | 1.5 | 11.4/10.6 | 4.25/4.04 |
POL-GIK (1999) | 954 | 62/60 | 70/67.2 | 94.1/97 | 6.5/6.1 | 10 | 32 | 0.3 | 42 ml/h | 5 | 5.9/6.2 |
GIPS-I (2003) | 940 | 59.9/60.8 | 73.7/79.3 | 89.5/92.7 | 10.5/10.6 | 20 | 7-11 | 0.3 | 3 | 2.75-2.78/2.75-2.82 | 7.7/8.1* |
REVIAL (2004) | 312 | 60.8/64.1 | 71.6/72.6 | 67.7/69.4 | 22.6/23.6 | 20 | 40 | 0.25 | 1.8 | - | - |
CREATE-ECLA (2005) | 20201 | 58.6/58.6 | 77.6/77.6 | 84.2/85.1 | 17.6/17.8 | 25 | 50 | 0.3 | 1.5 | 4.7/4.7¶ | 8.6/7.5 |
Krljanac G (2005) | 118 | 56.6/56.7 | 66.7/72.5 | - | 17/17 | 25 | 50 | 0.3 | 1 | 3.1/3.2 | - |
GIPS-II (2006) | 889 | 61.8/61.2 | 73/74 | 100/100 | 9/10 | 20 | 0.3 | 2 | - | - | |
OASIS-6 (2007) | 2748 | 61.5/62.1 | 73.1/71.7 | - | 14.9/14.0 | 25 | 50 | 0.3 | 1.5 | - | 8.5/7.5 |
IMMEDIATE (2012) | 871 | 63.9/63.3 | 72.5/69.6 | - | 29.4/26.3 | 30 | 25 | 0.6 | 1.5 | 1.5/1.5 | - |